Randomized clinical trial to evaluate a routine full anticoagulation Strategy in Patients with Coronavirus Infection (SARS-CoV2) admitted to hospital: Rationale and design of the ACTION (AntiCoagulaTlon cOroNavirus)–Coalition IV trial

Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19

(2021) Renato D. Lopes et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial

(2021) Viviane C Veiga et al.   BMJ-British Medical Journal

Abnormal Coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia

(2020) Ning Tang et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

(2020) Nanshan Chen et al.   LANCET

COVID-19 and the cardiovascular system

(2020) Ying-Ying Zheng et al.   Nature Reviews Cardiology

Autopsy Findings and Venous Thromboembolism in Patients With COVID-19

(2020) Dominic Wichmann et al.   ANNALS OF INTERNAL MEDICINE

Coagulopathy of Coronavirus Disease 2019

(2020) Toshiaki Iba et al.   CRITICAL CARE MEDICINE

High incidence of venous thromboembolic events in anticoagulated severe COVID‐19 patients

(2020) Jean‐François Llitjos et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy

(2020) Ning Tang et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19

(2020) Marisa Dolhnikoff et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

(2020) Fei Zhou et al.   LANCET

Creating a Framework for Conducting Randomized Clinical Trials during Disease Outbreaks

(2020) Natalie E. Dean et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rivaroxaban in Peripheral Artery Disease after Revascularization

(2020) Marc P. Bonaca et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19

(2020) Maximilian Ackermann et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis

(2020) Giuseppe Lippi et al.   PROGRESS IN CARDIOVASCULAR DISEASES

Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China

(2020) Shaobo Shi et al.   JAMA Cardiology

Post-discharge thrombosis and hemorrhage in patients with COVID-19

(2020) Rushad Patell et al.   BLOOD

Prevention, Diagnosis, and Treatment of VTE in Patients With Coronavirus Disease 2019

(2020) Lisa K. Moores et al.   CHEST

Randomized Trials Versus Common Sense and Clinical Observation

(2020) Alexander C. Fanaroff et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19

(2020) Alexandre B. Cavalcanti et al.   NEW ENGLAND JOURNAL OF MEDICINE

Incidence of thrombotic complications in critically ill ICU patients with COVID-19

(2020) F.A. Klok et al.   THROMBOSIS RESEARCH

Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19

(2020) Bruno M. Tomazini et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Anticoagulation in COVID-19

(2020) Renato D. Lopes et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19

(2020) Girish N. Nadkarni et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Anticoagulant interventions in hospitalized patients with COVID‐19: A scoping review of randomized controlled trials and call for international collaboration

(2020) Tobias Tritschler et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial

(2020) Remo H M Furtado et al.   LANCET

Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve

(2020) Helio P. Guimarães et al.   NEW ENGLAND JOURNAL OF MEDICINE

Advance in the Management of Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation

(2019) Toshiaki Iba et al.   Journal of Clinical Medicine

Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease

(2017) John W. Eikelboom et al.   NEW ENGLAND JOURNAL OF MEDICINE

Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolism

(2016) Maureen A. Smythe et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

The Emergence of the Randomized, Controlled Trial

(2016) Laura E. Bothwell et al.   NEW ENGLAND JOURNAL OF MEDICINE

A win ratio approach to comparing continuous non-normal outcomes in clinical trials

(2016) Duolao Wang et al.   PHARMACEUTICAL STATISTICS

Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH

(2015) S. Kaatz et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism

(2012)   NEW ENGLAND JOURNAL OF MEDICINE

Standardized Bleeding Definitions for Cardiovascular Clinical Trials

(2011) Roxana Mehran et al.   CIRCULATION

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

(2011) Manesh R. Patel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rivaroxaban in Patients with a Recent Acute Coronary Syndrome

(2011) Jessica L. Mega et al.   NEW ENGLAND JOURNAL OF MEDICINE